ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature

BACKGROUND: Although anaplastic lymphoma kinase (ALK) fusion genes are generally identified in lung adenocarcinoma patients, they are relatively rare in patients with squamous cell carcinoma (SqCC). Metastatic ALK-rearranged lung adenocarcinoma patients treated with ALK inhibitors demonstrate higher...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Mamesaya, Nobuaki, Nakashima, Kazuhisa, Naito, Tateaki, Nakajima, Takashi, Endo, Masahiro, Takahashi, Toshiaki
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501098/
https://ncbi.nlm.nih.gov/pubmed/28683775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3468-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki